| INTRODUCTION
Meningoencephalomyelitis of unknown origin (MUO), accounting for 25% of inflammatory central nervous system (CNS) disease in dogs, is suspected to be caused by an immune-mediated process. 1 Treatment with immunosuppressant drugs such as corticosteroids can alleviate clinical signs and delay disease progression. This suggests that dog inflammatory CNS disease is an immune-mediated disease, but whether the immune response is targeting an infection or is autoimmune is a critical open question.
Abbreviations: CNS, central nervous system; CSF, cerebrospinal fluid; CSU, Colorado State University; DWI, diffusion-weighted image; FLAIR, fluid-attenuated inversion recovery; GME, granulomatous meningoencephalomyelitis; GRE, gradient-recalled echo; MUO, meningoencephalomyelitis of unknown origin; PCR, polymerase chain reaction; PD, proton density; RBC, red blood cells; STIR, short tau inversion recovery; T1W, T1-weighted; T2W, T2-weighted; WSU, Washington State University A multitude of infectious agents are on the differential list for dogs with focal or multifocal neurological dysfunction, including bacterial, rickettsial, fungal, protozoal, and viral agents. 2, 3 Preliminary research searching for an infectious etiology has failed to reveal a common infectious agent. 1, [3] [4] [5] [6] Within the past 15 years, various groups have utilized polymerase chain reaction (PCR), serology, culture, or immunohistochemistry to investigate viruses commonly implicated in CNS disease, but bacterial diseases, in particular bartonellosis, have not been studied extensively. [5] [6] [7] A number of Bartonella spp. infected dogs. 8, 9 In a recent multicentre study, prospectively collected CSF and brain tissue from 109 dogs with neurological signs was tested by PCR for Ehrlichia, Anaplasma, Spotted Fever Group Rickettsia, Bartonella, and Borrelia species. Bartonella vinsonii subsp. berkhoffii DNA was amplified in the brain tissue from 1 of 6 histopathologically confirmed cases of granulomatous meningoencephalomyelitis (GME), a type of MUO. 3 Based on the findings of that study, this paper focused its investigation on the role of Bartonella spp. in the pathogenesis of inflammatory CNS disease in a larger antemortem population of dogs.
Bartonella henselae and B. clarridgeaie are transmitted by Ctenocephalides felis, and most cases of Bartonella spp. infection are identified in areas with high humidity and the presence of C. felis. 10 Colorado is semi-arid and so has few C. felis infestations or cats with evidence of Bartonella spp. exposure. 11 However, dogs do develop Bartonella spp.
endocarditis in this area. 12 Human cases of neurobartonellosis can occur in immunocompetent patients. [13] [14] [15] [16] [17] [18] [19] Bartonella spp. antibodies have likewise been detected in serum of some dogs with neurologic disease including meningoencephalitis, meningoradiculoneuritis, meningitis, and myelitis. 8, [20] [21] [22] [23] The primary objective of this study was to report the prevalence of Bartonella spp. in client-owned dogs, with and without inflammatory CNS disease, with a commercially available PCR assay. A secondary objective was to stratify the results into groups of dogs with and without inflammatory CNS disease and by region where the exposure was likely to occur. It was hypothesized that Bartonella spp. DNA would be amplified more commonly from the CSF of dogs with inflammatory disease compared to those without in areas endemic for fleas. 
| MATERIALS AND METHODS

| Selection criteria
| Bartonella spp. PCR assay
The remnant CSF samples had been stored at −80 C in monitored freezers until processed for this study. The frozen CSF samples (total volumes ranging from 100 to 550 μL) were thawed at room temperature and were ultracentrifuged at 10 000g for 15 minutes. The supernatant was discarded, and the pellet (5 μL CSF mixed with 50 μL of PCR reaction mix) was assayed according to a previously published, single-tube, conventional PCR assay targeting the 16S-23S rRNA intergenic region. 27 In previous titration experiments, this assay was shown to amplify B. henselae DNA from 100% of samples were greater than 50 colony forming units per mL. 27 In unpublished experiments, the extraction method was used on CSF samples from dogs with varying nucleated cell counts to determine whether DNA was extracted by amplifying glyceraldehyde 3-phosphate dehydrogenase (GAPDH); all samples with >15 nucleated cells per μL were positive. In this study, all positive amplicons were sequenced to confirm the detected Bartonella spp. The median age of the dogs with inflammatory CNS disease was 5 years (range, 2.4 months to 13 years) and the median age of the dogs with noninflammatory CNS disease was 7 years (2.0 months to 15 years); this difference was statistically significant, P = .010). Of the dogs with inflammatory CNS disease, there were 32 males and 33 females, and of the dogs without inflammation, there were 65 males and 42 females. There were no differences in sex distributions between the groups (P = .16).
| Statistical evaluation
In the group classified with inflammatory CNS disease, there were 9 mixed breed (13.8%), 5 pugs (7.7%), 5 Labrador Retrievers (7.7%), The results of the neuroanatomic localizations, MRI characteristics, and administration of glucocorticoids before diagnostic imaging and CSF collection are summarized in Table 2 .
The proportion of dogs with different types of CSF inflammation
by group is shown in Table 1 There were neither significant differences between lymphocytic and 
| DISCUSSION
Inflammatory and infectious diseases of the CNS are an important group of disorders, as they often cause severe neurologic dysfunction and can result in death of the dog. Meningoencephalitis of unknown origin is a relatively common condition in dogs whose etiopathogenesis remains elusive. Antemortem diagnosis relies on neurologic signs, CSF, MRI, and infectious disease testing, with histopathology necessary for definitive diagnosis. 28 Infectious agents thought to cause neurologic disease in dogs include rickettsial, viral, fungal, bacterial, and protozoans, in particular T. gondii and N. caninum. 2, 3 In a recent study, Bartonella was isolated in the brain tissue of one dog. 3 Failure to amplify Bartonella spp. DNA from the CSF of the 65 dogs with inflammatory disease in this study suggests either the organism was not a causal agent, the organism was in the CNS tissues but not in the CSF, or the organism was present but in quantities undetectable by this PCR assay. There might be selection bias in the population of dogs presented to tertiary hospitals and, therefore, included in this study. Because the application of flea and tick prevention reduces the infection rate, at least in experimentally infected cats, it could be speculated that pets belonging to families who have financial resources permitting them to proceed with MRI and CSF analyses, are also more likely to be treated with monthly flea and tick prevention and are consequently at less risk for bartonellosis. 29 This remains speculation, however, since the use of such preventives were not noted in the medical records to which we had access.
Of the 172 CSF samples, only one was positive for B. henselae Diagnosis of bartonellosis is complex, clinically, microbiologically, and pathologically. This is attributable to many factors related to the numerous species within the genus Bartonella, antigenic and virulence differences among strains and subspecies, and the diverse cell tropism. In addition, the ability to induce persistent occult infections in both reservoir and nonreservoir hosts, and the extraordinarily low levels of bacteremia found in nonreservoir hosts, make diagnosing bartonellosis challenging. 16 A limitation of this study was the application of PCR alone in the detection of Bartonella spp. The combination of PCR and culture has been found to be the most sensitive way to detect Bartonella spp. in samples from dogs and humans and the use of that technique should be considered in future studies. 16 Negative results in single PCR assays may not fully exclude Bartonella spp. from the differential list.
Another limitation of this study was the unavailability of historical information regarding prior or concurrent use of antibiotics in these dogs. However, Bartonella DNA is frequently detected, and a microbiological diagnosis achieved, despite antibiotic treatment. 30 This might reflect a high proportion of treatment failure, as previously suspected.
Similarly, there was no statistical association with enhanced PCR detection and glucocorticoids in that study; however, few dogs were treated with glucocorticoids. Whether glucocorticoids treatment might facilitate molecular diagnosis of bartonellosis remained uncertain.
Inflammatory CNS disease is commonly identified with infectious causes being rarely detected. Management with judicious use of immunosuppressive therapies in many of these cases affords a positive outcome. [31] [32] [33] [34] [35] Immunosuppression in the face of infection by N. caninum can lead to exacerbation of the disease, which can have a fatal outcome. 36, 37 The results presented here further demonstrate that T. gondii, N. caninum, and Bartonella spp. infections are rarely identified in dogs with the neurological manifestations reported here.
Despite this, screening for these and other infectious agents before immune suppression is prudent because the consequences could be catastrophic.
In this study, toy breed dogs predominated in the inflammatory CSF group, with samples from pugs and Chihuahuas representing 7.7 39 This likely represents a regional difference in the population of preferred breeds but it demonstrates that inflammatory CNS disease should be considered in large breed dogs.
| CONCLUSIONS
Similar to other reports, an apparent role of Bartonella spp., T. gondii, and N. caninum in dog inflammatory CNS disease was not identified. 
